Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock
Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
Read More 2 minute read Pharma Industry News FDA rejects Correvio Pharma’s anti-arrhythmic drug Brinavess Correvio Pharma said that the US Food and Drug Administration (FDA) decided not to approve its anti-arrhythmic drug… bypharmanewsdailyDecember 25, 2019